| Literature DB >> 27773693 |
Anna Walter1, Claudia Suenderhauf2, Fabienne Harrisberger3, Claudia Lenz3, Renata Smieskova3, Yoonho Chung4, Tyrone D Cannon4, Carrie E Bearden5, Charlotte Rapp6, Kerstin Bendfeldt7, Stefan Borgwardt3, Tobias Vogel3.
Abstract
Several magnetic resonance imaging studies have reported reductions in hippocampal volume in patients with psychosis. It is unclear whether structural abnormalities predate illness onset. We conducted a detailed, systematic literature search for studies reporting hippocampal volume in subjects with clinical high-risk, compared to healthy controls. The overall sample size comprised 1429 subjects. Meta-analysis revealed no difference for left, but a small, albeit significant, difference for right hippocampal volume, such that clinical high-risk patients had slightly smaller hippocampal volume than healthy controls (g=0.24, p=0.0418). Meta-regression indicated a moderating effect of manual tracing approach, due to one outlying site. The small difference on the right side did not remain significant (g=0.14, 95%CI=[-0.03-0.32], p=0.11) after removal of this outlier. This meta-analysis suggests that there is no reduction in hippocampal volume before transition to psychosis and hippocampal volume cannot be used as a biomarker in clinical high-risk individuals. Copyright ÂEntities:
Keywords: At-risk mental state; Biomarker; Clinical high-risk; Early detection; Hippocampus; Magnetic resonance imaging; Psychosis; Ultra high-risk
Mesh:
Year: 2016 PMID: 27773693 DOI: 10.1016/j.neubiorev.2016.10.007
Source DB: PubMed Journal: Neurosci Biobehav Rev ISSN: 0149-7634 Impact factor: 8.989